उत्पाद वर्णन
Description
- Each film coated tablet contains: Nateglinide 60 mg Metformin HCL IP 500 mg (as sustained release),
Indication
- Nateglinide alone and in combination with metformin improves glycemic control by reducing mealtime glucose levels in type 2 diabetes.
Highly Efficient Diabetes ManagementThis combination tablet brings together the fast-acting benefits of Nateglinide and the extended glucose-lowering effects of sustained-release Metformin. The dual-action formula is intended to support stable and effective glycemic control for individuals requiring regular diabetes management.
Sustained Release TechnologyThe sustained-release formulation ensures a controlled release of Metformin over time, reducing the frequency of dosing while helping to minimize gastrointestinal side effects. This provides patients with added convenience and can contribute to improved treatment adherence.
Ideal for Wholesale and DistributionManufactured in India and designed for diverse markets, this product is available for dealers, wholesalers, exporters, importers, and distributors. Its 2-year shelf life and robust supply chain support make it suitable for large-scale procurement and distribution across various channels.
FAQ's of Nateglinide 60 mg Metformin HCL IP 500 mg (as sustained release), tab:
Q: How should Nateglinide 60 mg Metformin HCL IP 500 mg sustained-release tablets be stored?
A: These tablets should be stored in a cool environment, away from direct sunlight and moisture, to maintain their effectiveness throughout their 2-year shelf life.
Q: What are the key ingredients in this tablet and what is their purpose?
A: Each tablet contains 60 mg of Nateglinide, which stimulates insulin release, and 500 mg of Metformin HCL in sustained-release form, which helps control glucose production and absorption. Together, they manage blood sugar levels effectively.
Q: When is it recommended to use this combination medication?
A: This medication is typically prescribed as part of a treatment plan for individuals with type 2 diabetes mellitus, particularly when single-drug therapy does not offer sufficient glycemic control.
Q: Where is this product manufactured and available for distribution?
A: The tablets are manufactured in India and are available through a wide network of dealers, distributors, exporters, importers, and wholesalers throughout the country.
Q: What is the appearance of the Nateglinide and Metformin sustained-release tablet?
A: These tablets are white to off-white capsules and may contain some colored specks, in accordance with the described appearance specification.
Q: What is the benefit of the sustained-release feature in this product?
A: The sustained-release formulation allows Metformin to be released gradually, offering extended glucose control, reducing dosing frequency, and improving patient convenience and compliance.